We are live on ! Find out more
MCM

Matarin Capital Management Portfolio holdings

AUM $409M
1-Year Est. Return 33.03%
This Fund
S&P 500
This Quarter Est. Return
+7.93%
1 Year Est. Return
+33.03%
3 Year Est. Return
+73.2%
5 Year Est. Return
+181.87%
10 Year Est. Return
–
AUM
$1.18B
AUM Growth
+$95.8M
Cap. Flow
+$38.3M
Cap. Flow %
3.25%
Top 10 Hldgs %
12.78%
Holding
316
New
41
Increased
130
Reduced
90
Closed
25

Top Buys

Rank Stock Value
1
MDXG icon
MiMedx Group
MDXG
+$10.3M
2
OMF icon
OneMain Financial
OMF
+$8.99M
3
DPLO
DIPLOMAT PHARMACY, INC.
DPLO
+$8.85M
4
PRLB icon
Protolabs
PRLB
+$8.64M
5
MTOR
MERITOR, Inc.
MTOR
+$8.4M

Top Sells

Rank Stock Value
1
MTZ icon
MasTec
MTZ
+$14.6M
2
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
+$8.16M
3
DFT
DuPont Fabros Technology Inc.
DFT
+$7.88M
4
PZZA icon
Papa John's
PZZA
+$7.27M
5
AHL
ASPEN Insurance Holding Limited
AHL
+$7.17M

Sector Composition

Rank Sector Weight
1 Financials 17.52%
2 Industrials 14.47%
3 Technology 13.37%
4 Consumer Discretionary 12.24%
5 Healthcare 10.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PAHC icon
301
Phibro Animal Health
PAHC
$1.5B
– –
-8,118
Closed -$301K
HTO
302
H2O America
HTO
$2.67B
– –
-20,030
Closed -$985K
STRL icon
303
Sterling Infrastructure
STRL
$15.2B
– –
-13,071
Closed -$171K
UAL icon
304
United Airlines
UAL
$38.8B
– –
-63,115
Closed -$4.75M
EQC
305
DELISTED
Equity Commonwealth
EQC
– –
-16,068
Closed -$508K
EGRX
306
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
– –
-103,444
Closed -$8.16M
VRTV
307
DELISTED
VERITIV CORPORATION
VRTV
– –
-16,879
Closed -$760K
CTXS
308
DELISTED
Citrix Systems Inc
CTXS
– –
-18,961
Closed -$1.51M
CZZ
309
DELISTED
Cosan Limited
CZZ
– –
-33,388
Closed -$214K
LKSD
310
DELISTED
LSC Communications, Inc.
LKSD
– –
-43,731
Closed -$936K
AHL
311
DELISTED
ASPEN Insurance Holding Limited
AHL
– –
-143,785
Closed -$7.17M
ECYT
312
DELISTED
Endocyte, Inc. Common Stock
ECYT
– –
-39,307
Closed -$59K
WLB
313
DELISTED
Westmoreland Coal Company
WLB
– –
-206,539
Closed -$1.01M
BIVV
314
DELISTED
Bioverativ Inc. Common Stock
BIVV
– –
-7,369
Closed -$443K
DFT
315
DELISTED
DuPont Fabros Technology Inc.
DFT
– –
-128,781
Closed -$7.88M
CDI
316
DELISTED
CDI Corp.
CDI
– –
-15,247
Closed -$89.2K
9 10 11 12
13

Similar funds

GBBWRPM
Genovese Burford & Brothers Wealth & Retirement Plan Management Sacramento, California $400M AUM 14.87% 1-Year Est. Return
PSSGI
P-STS SPV GP IA San Francisco, California $433M AUM
RA
Reby Advisors Danbury, Connecticut $382M AUM
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
SIVVM
SC Israel Venture V Management Herzelia, Israel $373M AUM
SM
Scale Management Foster City, California $359M AUM
NFG
NewFocus Financial Group Vancouver, Washington $340M AUM 17.91% 1-Year Est. Return
AWW
Alan W. Weber $336M AUM 75.94% 1-Year Est. Return

Matarin Capital Management's Q3 2017 Portfolio in Review

As of Q3 2017, Matarin Capital Management held 316 positions worth $1.18B, up 8.9% from $1.08B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Matarin Capital Management deployed $38.3M of net new capital in Q3 2017, opening 41 new positions and adding to 130 existing holdings. Its largest new stake was MiMedx Group: 694,135 shares worth $8.25M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 17% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Papa John's, an estimated $7.27M trimmed.

  • Matarin Capital Management's largest Q3 2017 buy was MiMedx Group: 694,135 shares worth $8.25M.
  • Matarin Capital Management added most to Protolabs in Q3 2017, an estimated $8.64M increase.
  • Matarin Capital Management's biggest Q3 2017 reduction was Papa John's, cutting an estimated $7.27M.
  • Matarin Capital Management fully exited MasTec in Q3 2017, selling an estimated $14.6M.
  • Matarin Capital Management's ten largest holdings make up 13% of its $1.18B portfolio in Q3 2017.
  • Matarin Capital Management opened 41 new positions and closed 25 in Q3 2017.
  • Matarin Capital Management's portfolio value rose 8.9% quarter-over-quarter to $1.18B.

Based on Matarin Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.